Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
6,273,457
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
18,829
-
Shares change
-
+11,594
-
Total reported value, excl. options
-
$57,207
-
Value change
-
+$35,228
-
Number of buys
-
5
-
Number of sells
-
2
-
Price
-
$3.02
Institutional Holders of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) as of Q2 2024
As of 30 Jun 2024 TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,829 shares of stock of the company.
Largest 10 holders included GEODE CAPITAL MANAGEMENT, LLC, Qube Research & Technologies Ltd, UBS Group AG, Tower Research Capital LLC (TRC), CIBC Private Wealth Group, LLC, BlackRock Inc., MORGAN STANLEY, BANK OF AMERICA CORP /DE/, FMR LLC, and Allworth Financial LP.
This table shows 10 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.